Dr. Carlos Correa discusses the impact of evergreening strategies on access to generic and biosimilar medicines globally.

According to a report published by EY on January 15, the IPO activity in the United States remained strong in 2024 and is expected to continue at an accelerated pace in 2025.

The Proframe RS Helmet elevates the lightweight breathability characteristic of Fox’s beloved Proframe and uses enhanced ...